Related Experiment Video
Updated: Apr 10, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X)
Michela Cappella1, Vanna Graziani1, Antonella Pragliola2
1Department of Paediatrics, Santa Maria delle Croci Hospital, 48121 Ravenna, Italy.
We report four infants with mosaic r(X) Turner genotype and hyperinsulinemic hypoglycemia (HH). These cases highlight a rare association, with patients responding well to diazoxide therapy, crucial for preventing neurological damage.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Hyperinsulinemic hypoglycemia (HH) is a heterogeneous disorder of pancreatic beta-cell insulin secretion.
- HH can be congenital or associated with metabolic and syndromic conditions.
- Early diagnosis and management are critical to prevent neurological sequelae.
Purpose of the Study:
- To report on a rare association between mosaic r(X) Turner syndrome and hyperinsulinemic hypoglycemia.
- To describe the clinical presentation and treatment response in affected infants.
Main Methods:
- Case series of four infants diagnosed with mosaic r(X) Turner genotype and hyperinsulinemic hypoglycemia.
- Evaluation of diazoxide responsiveness for treatment.
Main Results:
- Four cases of infants with mosaic r(X) Turner genotype and hyperinsulinemic hypoglycemia were identified.
- All reported cases showed positive response to diazoxide therapy.
- This represents a significant increase in the number of reported cases of this rare association.
Conclusions:
- Mosaic r(X) Turner syndrome is a rare but significant cause of hyperinsulinemic hypoglycemia in infants.
- Diazoxide therapy appears effective in managing HH in this specific patient population.
- Further research is warranted to understand the underlying mechanisms of this association.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

